Reading time: 4 minutes Share this article: Biologics manufacturing has long depended on raw materials like fetal bovine serum (FBS), plasma fractions, and albumin derived from human or animal donors. While these components have supported cell growth and product stability, they also introduce serious hidden risks that affect quality, compliance, and patient safety. Here’s …
Reading time: 4 minutes Share this article: Biomanufacturers know that raw material quality directly impacts safety, consistency, and regulatory success. But what many teams overlook are the invisible costs—financial, operational, and regulatory—associated with blood- and animal-derived inputs. Whether it’s human serum albumin (HSA), transferrin, insulin, or other plasma proteins, blood-derived raw materials introduce a …
Reading time: 4 minutes Share this article: Cancer cells have a sneaky habit. Just when it seems chemotherapy is getting the upper hand, they adapt, pumping drugs out faster than they come in. It’s called multidrug resistance (MDR), and it’s a major roadblock in treating cancers like breast, lung, and pancreatic. But what if …
